Загрузка...
INSIGHT FLU005: An Anti–Influenza Virus Hyperimmune Intravenous Immunoglobulin Pilot Study
Hemagglutination inhibition (HAI) antibody responses to anti–influenza virus hyperimmune intravenous immunoglobulin (hIVIG) were characterized. Thirty-one patients with influenza during the 2013–2014 season were randomly assigned to receive 0.25 g/kg of hIVIG (n = 16) or placebo (n = 15). For hIVIG...
Сохранить в:
| Опубликовано в: : | J Infect Dis |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4721910/ https://ncbi.nlm.nih.gov/pubmed/26374911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiv453 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|